To provide incentives for investment in research and development for new medicines, to enhance access to new medicines, and for other purposes.
The bill’s titles are written by its sponsor.
Jan 26, 2005
109th Congress, 2005–2006
Died in a previous Congress
This bill was introduced on January 26, 2005, in a previous session of Congress, but was not enacted.
Representative for Vermont At Large
Read Text »
Last Updated: Jan 26, 2005
Length: 21 pages
Jan 26, 2005
Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.
Oct 19, 2007
Reintroduced Bill — Introduced
This activity took place on a related bill, S. 2210 (110th).
H.R. 417 (109th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
This bill was introduced in the 109th Congress, which met from Jan 4, 2005 to Dec 9, 2006. Legislation not enacted by the end of a Congress is cleared from the books.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
Civic Impulse. (2017). H.R. 417 — 109th Congress: Medical Innovation Prize Act of 2005. Retrieved from https://www.govtrack.us/congress/bills/109/hr417
“H.R. 417 — 109th Congress: Medical Innovation Prize Act of 2005.” www.GovTrack.us. 2005. September 23, 2017 <https://www.govtrack.us/congress/bills/109/hr417>
|title=H.R. 417 (109th)
|accessdate=September 23, 2017
|author=109th Congress (2005)
|date=January 26, 2005
|quote=Medical Innovation Prize Act of 2005
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.